Navigation Links
Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid
Date:8/23/2011

MISSISSAUGA, Ontario, Aug. 23, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (the "Company" or "Valeant") announced today that it has filed a Notice of Intention to make a normal course issuer bid with The Toronto Stock Exchange (the "TSX") and that the TSX has accepted the Notice of Intention. Under the bid, the Company will have the right to purchase for cancellation, commencing August 25, 2011, 1,000,000 of its Common Shares (representing approximately 0.33% of Valeant's Common Shares issued and outstanding as of the date hereof) through the facilities of the TSX, or such other means as may be permitted by the TSX. The Company may, at certain times, purchase its Common Shares if it believes that the market price of its Common Shares is attractive and that the purchase would be in the best interest of the Company and an appropriate use of corporate funds in light of potential benefits to remaining shareholders. The Company currently has approximately 299,587,764 Common Shares outstanding, and its average trading volume on the TSX for the six months prior to the date hereof is 462,572. For purposes of the TSX rules, a maximum of 115,643 common shares may be purchased by the Company on any one day under the bid, except where purchases are made in accordance with the "block purchase exception" of the TSX rules.

The normal course issuer bid is part of the Company's previously announced Securities Repurchase Program, pursuant to which the Company's Board of Directors has approved the purchase of up to 16 million Common Shares (representing approximately 10% of the Company's public float at the date of the announcement of the Securities Repurchase Program), 15 million of which have been approved for repurchase through the facilities of the NYSE (representing approximately 5% of Valeant's issued and outstanding common shares as of the date of the announcement of the Securities Repurchase Program). The Company currently intends to purchase th
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
2. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
3. Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results
4. Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada
5. Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta™ in Canada
6. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
7. Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
8. Valeant Pharmaceuticals Agrees to Acquire Dermik
9. Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese™
10. Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
11. Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...
(Date:6/18/2013)... CAMPBELL, Calif. , June 18, 2013 /PRNewswire/ ... company focused on the development of next-generation atrial ... Patent No. 8295902 by the US Patent and ... patent encompasses low profile electrode assemblies for use ... endovascular ablation or other surgical procedures. ...
(Date:6/17/2013)... WASHINGTON , June 17, 2013 ... ) presented additional data today at ENDO 2013, ... demonstrating that tasimelteon can entrain (synchronize) both melatonin ... potential to reset the master body clock and ... Non-24-Hour Disorder (Non-24).  The SET (Safety and Efficacy ...
Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4
(Date:6/18/2013)... Destin, FL (PRWEB) June 18, 2013 ... coast by storm. The burgeoning aquaculture industry is redefining ... Jekyll, one of the most acclaimed personal culinary chefs ... his clientele on benefits of sustainable seafood and the ... used in abundance these days. Many consumers strive to ...
(Date:6/18/2013)... As Mirena lawsuit claims continue to ... report has revealed that that the IUD has been the ... (FDA) adverse event reports since coming on the market in ... Mirena users have reported device dislocation or migration to the ... uterine perforations due to Mirena.* , “We are not at ...
(Date:6/18/2013)... NY (PRWEB) June 18, 2013 New York ... Center to its “Best Doctors” list, up from 129 ... York City. The new issue also lists 52 additional doctors ... continues on a strategic growth trajectory. The “Best Doctors” issue, ... in the June 24 print issue and is available online ...
(Date:6/18/2013)... -- Lauren Sciences, a privately-held biotechnology company furthering ... announced today that it was independently recognized as ... V-Smart Platform, and selected as a Featured Company, ... , The report, " Early Stage Drug ... ," features companies MCD Group independently selected as ...
(Date:6/18/2013)... People with HIV are more likely to keep their ... if they feel their physician listens, explains things ... a "case," new Johns Hopkins research suggests. , "If ... to them, they feel that doctor has their best ... follow medical advice," says study leader Tabor E. Flickinger, ...
Breaking Medicine News(10 mins):Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 3Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:Respect may be the key to stopping patient 'no shows' 2
... for white bread pause to hear this. New reports show ... white bread could lead to cancer of the kidneys. // ... come to conclusion that use of excessive refined flour in ... which in turn stimulates the release of insulin into the ...
... as a magic bullet for obesity — rimonabant (Acomplia) — ... and also helps lower cardiac risk factors, according to a ... Europe in July, and U.S. approval is pending before the ... way, suppressing the appetite by targeting the brain cells involved ...
... and Mentor Corp. breast implant makers on Friday said that ... silicone gel breast implants back on the market. // ... Health Canada has granted the company a license for sale ... well as Style 410 Shaped and Textured implants. Earlier this ...
... been formally launched by the Chief Minister Y. S. ... temple area of Pardiwada in Maharajgunj constituency here. // ... impetus on the phasing out of the dustbin system ... supplied with small plastic bins. Garbage collectors on cycle ...
... Virginia University professor and two alumni have tracked the ... the eye and often leads to blindness and death.// ... treatment for those who suffer from it. ,Joginder ... doctoral students Jason White ('02) and Alison Director-Myska ('96) ...
... the gut has been found to be an effective ... researchers at Cedars-Sinai Medical Center. ,The study ... the Annals of Internal Medicine It is the ... end of the course of treatment has ended. This ...
Cached Medicine News:Health News:Latest Weight-Loss Pill Offers Modest Results, Blocks 'Munchies' 2Health News:Latest Weight-Loss Pill Offers Modest Results, Blocks 'Munchies' 3Health News:YSR launches 'Operation Dengue' 2Health News:Team Tracks Genetic Origins of Eye Cancer 2Health News:IBS Sufferers Benefited by Non-Absorbable Antibiotics 2
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... diagnosis of influenza A and ... due to the availability of ... of influenza using Clearview Exact ... lead to reduced hospital stays, ...
... A1c-Cellular is the first HbA1c control available ... the entire HbA1c procedure including the lysing ... is a ready-to-use liquid control with an ... closed-vial stability of six months when refrigerated. ...
...
Medicine Products: